Braemar Hotels & Resorts Inc
Change company Symbol lookup
Select an option...
BHR Braemar Hotels & Resorts Inc
ESALY Eisai Co Ltd
CNX CNX Resources Corp
WW WW International Inc
IBM International Business Machines Corp
NEP Nextera Energy Partners LP
TMP Tompkins Financial Corp
MFM MFS Municipal Income Trust
HMNKF HMS Networks AB
GPX GP Strategies Corp
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Value
Company profile

Braemar Hotels & Resorts Inc., formerly Ashford Hospitality Prime, Inc., invests in high revenue per available room (RevPAR), luxury hotels and resorts. The Company conducts its business and owns all of its assets through its operating partnership, Ashford Hospitality Prime Limited Partnership (Ashford Prime OP). The Company operates in the direct hotel investment segment of the hotel lodging industry. As of February 24, 2017, it owned interests in 11 hotel properties in six states, the District of Columbia and St. Thomas, the United States Virgin Islands with 3,702 total rooms, or 3,467 net rooms, excluding those attributable to its joint venture partner. The hotel properties in its portfolio are mainly located in the Unites States urban markets. The Company owns nine of its hotel properties directly, and the remaining two hotel properties through an investment in a majority-owned consolidated entity.

Closing Price
$2.39
Day's Change
-0.04 (-1.65%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.50
Day's Low
2.34
Volume
(Average)
Volume:
264,351

10-day average volume:
279,327
264,351

UPDATE: Consumer goods drive record in seaborne imports to U.S. in August, and medical test kits may have peaked, report finds

6:09 am ET September 10, 2020 (MarketWatch)
Print

By Ciara Linnane, MarketWatch

Imports of testing kits fell 35.1% in August from the year-earlier period and were down 11.6% from July after June's surge

Seaborne imports to the U.S. set a record in August and were up 5.9% from the same period a year ago, according to a new report from Panjiva, the supply-chain research unit of S&P Global Market Intelligence.

Seaborne imports surpassed 2.7 million 20-foot equivalent units, a measurement of cargo capacity, for the first time, the report found. The trend was driven by demand for consumer products during the pandemic, with imports of discretionary products up 16.1% and staples up 34.9%, driven by food and personal-care shipments.

But there are also signs of an uptick in industrial demand, where imports rose 4.4%. That number reflects an 82.7% rise in shipments of agricultural equipment by Deere & Co. (DE) and Japan's Kubota Corp. (6326.TO)(6326.TO), as well as an 8.2% decline in construction machinery, among others.

Deere, headquartered in Moline, Ill., has suppliers in Germany and Japan, according to FactSet.

"A similar pattern can be seen in supplies, with electrical components up by 9.6% and building products down by 2.9%," Panjiva said in the report.

See: U.S. trade deficit surges 18.9% in July (http://www.marketwatch.com/story/us-trade-deficit-surges-189-in-july-2020-09-03)

Imports of medical-test-kit supplies needed for the pandemic fell in August, the report found, and may have peaked in June. Imports of testing kits alone were down 35.1% in August from a year ago, and were down 11.6% compared with July, after a surge in June.

There was a significant decline in test-kit shipments by Abbott Labs (ABT), which fell 72.7% in August from July, and Roche Holding AG (ROG.EB), which fell 50% from July. Imports linked to Johnson & Johnson (JNJ) fell the least, at just 3.3%.

Abbott, based in Abbott Park, Ill., near Chicago, has a supply chain that includes facilities in India, Vietnam and Israel, according to FactSet, while New Brunswick, N.J.-based Johnson & Johnson's includes a Japan location.

Abbott in August struck a $750 million deal with the Trump administration (http://www.marketwatch.com/story/trump-administration-makes-750-million-deal-to-buy-150-million-of-abbotts-new-coronavirus-tests-2020-08-27) to supply it with 150 million of the company's rapid-response COVID-19 antigen tests.

See:Here's what to know about Abbott's 15-minute COVID-19 test (http://www.marketwatch.com/story/heres-what-to-know-about-abbotts-15-minute-covid-19-test-11598982464)

Shipments of treatment supplies, including ventilators, fell 13.3%. Products in the protection, diagnostics and treatment category fell 13% in July from June.

Read also:Fed's Beige Book says U.S. economy improved in August but gains 'modest' (http://www.marketwatch.com/story/feds-beige-book-says-us-economy-improved-in-august-but-gains-modest-2020-09-02)

The report also looked at supply chains for telecom companies and found Ericsson (ERIC-B.SK) (ERIC-B.SK) and Samsung (005930.SE) may have a trade-policy edge over Nokia (NOKIA.HE)(NOKIA.HE) in 5G.

See also: The pandemic revealed the cracks in U.S. manufacturing. Here's how to fix them (http://www.marketwatch.com/story/the-pandemic-revealed-the-cracks-in-u-s-manufacturing-heres-how-to-fix-them-11599671092).

"Nokia's sourcing from China may prove to be a challenge, with 84.8% of U.S. seaborne imports linked to the firm coming from China in the 12 months to July 31," said the report. "For Samsung Electronics and Ericsson the ratio is much lower. In Ericsson's case it was just 10.8%, with a further 52.7% coming from Mexico."

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

September 10, 2020 06:09 ET (10:09 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.